Skip to main content Skip to footer

Press Releases

Bringing Science to Society™

Investors

Investors

  • Overview
  • Press Releases
  • Investor Events
  • Presentations
  • Governance
    • Governance Documents
    • Management Team
    • Board of Directors
    • Board Committees
  • Stock Information
    • Quote
    • Analyst Coverage
  • Financials & Filings
    • SEC Filings
Jul 01, 2015 9:15am EDT

Recro Pharma Announces $16 Million Financing

May 28, 2015 11:00am EDT

Recro Pharma to Present at the Jefferies 2015 Global Healthcare Conference

May 12, 2015 10:03pm EDT

Recro Pharma Reports First Quarter 2015 Financial Results

Apr 13, 2015 11:00am EDT

Recro Pharma Completes Acquisition of IV/IM Meloxicam and cGMP Manufacturing Facility and Business Unit From Alkermes

Apr 09, 2015 11:00am EDT

Recro Pharma Announces Update on On-Going Phase II Clinical Trial of Dex-IN for Treatment of Acute Pain on Day 1 Following Surgery

Mar 25, 2015 12:00pm EDT

Recro Pharma Reports Fourth Quarter and Full Year 2014 Financial Results

Mar 09, 2015 10:00am EDT

Recro Pharma to Acquire IV/IM Meloxicam and Gainesville, GA GMP Manufacturing Facility and Business Unit From Alkermes

Feb 03, 2015 1:00pm EST

Recro Pharma Enters Into Common Stock Purchase Agreement With Aspire Capital

Feb 02, 2015 9:22pm EST

Recro Pharma to Present at the 17th Annual BIO CEO & Investor Conference

Nov 10, 2014 12:00pm EST

Recro Pharma Reports Third Quarter 2014 Financial Results

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
Copyright ©2023 Societal CDMO. All rights reserved. Manage Cookie Preferences
Follow us